PPIB and Alzheimer disease: BCA may be used as a preventative and/or therapeutic agent for AD by binding the preformed fibril structure of β-amyloid25–35 and inhibiting β-amyloid25–35-induced apoptosis by suppressing caspase activity (Ghobeh et al., 2014; Tan and Kim, 2016).